INCY(Incyte Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $2.99B | $3.39B | $3.70B | $4.24B | $5.14B |
| 毛利润 | $2.84B | $3.19B | $3.44B | $3.93B | $4.77B |
| 营业利润 | $585.78M | $579.44M | $620.52M | $61.37M | $1.51B |
| 净利润 | $948.58M | $340.66M | $597.60M | $32.62M | $1.29B |
| 经营现金流 | $749.49M | $969.94M | $496.49M | $335.34M | $1.41B |
| 自由现金流 | $568.48M | $892.11M | — | — | — |
| 摊薄每股收益 | $4.27 | $1.52 | $2.65 | $0.15 | $6.41 |